The Veteran's claim for service connection for multiple myeloma (previously rated as solitary plasmacytoma) is granted, with an effective date of February 16, 2023.
The deciding factor: The Veteran submitted a fully developed claim on February 16, 2023, and completed a supplemental claim within one year of the intent to file. The new evidence supported reopening the previous denial of service connection for solitary plasmacytoma claimed as multiple myeloma.
- Claimed conditions
- multiple myeloma, solitary plasmacytoma
- How they argued it
- Reopened with new and material evidence
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- December 7, 2023
- Citation
- A23035102
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A23035102.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Veteran's claim for an initial rating in excess of 100 percent for service-connected multiple myeloma has been denied. The Board also remanded two issues related to nerve neuropathies, and the claims for TDIU and SMC have been denied.
- Remanded (sent back)
The Board has remanded the claims for service connection for multiple myeloma and back problems due to a duty to assist error. For multiple myeloma, the Veteran's exposure to asbestos is not verified. For back problems, an addendum opinion is needed to consider the Veteran's lay statements regarding her training-related injuries.
- Granted
The Board has granted service connection for multiple myeloma, finding that the evidence is in equipoise and resolving all reasonable doubt in favor of the appellant.
- Granted
The Board has granted service connection for multiple myeloma, diabetes mellitus II, and coronary artery disease (CAD) based on the Veteran's in-service exposure to herbicide agents.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.